|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/574 | |
| A61K 39/395 | |||
| A61K 45/00 | |||
| A61P 1/16 | |||
| A61P 35/00 | |||
| G01N 33/48 | |||
| G01N 33/53 | |||
| C07K 16/30 |
| (11) | Number of the document | 2937697 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13864465.3 |
| Date of filing the European patent application | 2013-12-24 | |
| (97) | Date of publication of the European application | 2015-10-28 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2013/007529 |
| Date | 2013-12-24 |
| (87) | Number | WO 2014/097648 |
| Date | 2014-06-26 |
| (30) | Number | Date | Country code |
| 2012280304 | 2012-12-21 | JP |
| (72) |
OHTOMO, Toshihiko, JP
AMANO, Jun, JP
NAKAMURA, Mikiko, JP
CHEN, Ya-Chi, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
Chugai Seiyaku Kabushiki Kaisha, 5-1, Ukima 5-chome, Kita-ku Tokyo 115-9543, JP |
| (54) | GPC3-TARGETED THERAPEUTIC AGENT FOR ADMINISTRATION TO PATIENTS FOR WHOM GPC3-TARGETED THERAPEUTIC AGENT THERAPY IS EFFECTIVE |
| GPC3-TARGETED THERAPEUTIC AGENT FOR ADMINISTRATION TO PATIENTS FOR WHOM GPC3-TARGETED THERAPEUTIC AGENT THERAPY IS EFFECTIVE |